Takeaway

• Androgen deprivation therapy (ADT) is associated with increased risk for diabetes but not for metabolic syndrome in patients with prostate cancer.

Why this matters

• Findings support the National Comprehensive Cancer Network guideline recommendations that ADT should not be initiated in patients with localized prostate cancer since it does not...